Gene expression signature predicting pathologic complete response with gemcitabine, epirubicin, and docetaxel in primary breast cancer.
Thuerigen O, Schneeweiss A, Toedt G, Warnat P, Hahn M, Kramer H, Brors B, Rudlowski C, Benner A, Schuetz F, Tews B, Eils R, Sinn HP, Sohn C, Lichter P.
Thuerigen O, et al. Among authors: schuetz f.
J Clin Oncol. 2006 Apr 20;24(12):1839-45. doi: 10.1200/JCO.2005.04.7019.
J Clin Oncol. 2006.
PMID: 16622258